SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
ý |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the quarterly period ended March 31, 2005 |
|
OR |
|
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the transition period from to |
|
Commission File Number 001-31788
NBTY, INC.
(Exact Name of Registrant as Specified in Its Charter)
| DELAWARE (State or Other Jurisdiction of Incorporation or Organization) |
11-2228617 (IRS Employer Identification No.) |
90 Orville Drive
Bohemia, New York 11716
(Address of Principal Executive Offices, Including Zip Code)
(631) 567-9500
(Registrant's Telephone Number, Including Area Code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ý NO o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES ý NO o
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
| Title of Class |
Shares Outstanding |
|
|---|---|---|
| Common Stock | as of May 6, 2005 | |
| Par value $.008 per share | 67,185,460 |
NBTY, INC. and SUBSIDIARIES
QUARTERLY REPORT ON FORM 10-Q
FISCAL QUARTER ENDED MARCH 31, 2005
INDEX
| |
|
Page |
|||
|---|---|---|---|---|---|
| PART I. | Financial Information | ||||
ITEM 1. |
Financial Statements (Unaudited) |
||||
Condensed Consolidated Balance Sheets |
3 |
||||
Condensed Consolidated Statements of Income |
4 |
||||
Condensed Consolidated Statements of Stockholders' Equity and Comprehensive Income |
5 |
||||
Condensed Consolidated Statements of Cash Flows |
6 |
||||
Notes to Condensed Consolidated Financial Statements |
7 |
||||
ITEM 2. |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
22 |
|||
ITEM 3. |
Qualitative and Quantitative Disclosures about Market Risk |
44 |
|||
ITEM 4. |
Controls and Procedures |
45 |
|||
PART II. |
Other Information |
||||
ITEM 1. |
Legal Proceedings |
46 |
|||
ITEM 4. |
Submission of Matters to a Vote of Security Holders |
48 |
|||
ITEM 6. |
Exhibits and Reports on Form 8-K |
48 |
|||
Signatures |
51 |
||||
Exhibits |
|||||
INFORMATION CONTAINED IN THIS FORM 10-Q CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 WITH RESPECT TO OUR FINANCIAL CONDITION, RESULTS OF OPERATIONS AND BUSINESS. ALL OF THESE FORWARD-LOOKING STATEMENTS, WHICH CAN BE IDENTIFIED BY THE USE OF TERMINOLOGY SUCH AS "SUBJECT TO," "BELIEVE," "EXPECTS," "PLAN," "PROJECT," "ESTIMATE," "INTEND," "MAY," "WILL," "SHOULD," "CAN," OR "ANTICIPATES," OR THE NEGATIVE THEREOF, OR VARIATIONS THEREON, OR COMPARABLE TERMINOLOGY, OR BY DISCUSSIONS OF STRATEGY WHICH, ALTHOUGH BELIEVED TO BE REASONABLE, ARE INHERENTLY UNCERTAIN. FACTORS WHICH MAY MATERIALLY AFFECT SUCH FORWARD-LOOKING STATEMENTS INCLUDE: (I) SLOW OR NEGATIVE GROWTH IN THE NUTRITIONAL SUPPLEMENT INDUSTRY; (II) INTERRUPTION OF BUSINESS OR NEGATIVE IMPACT ON SALES AND EARNINGS DUE TO ACTS OF WAR, TERRORISM, BIO-TERRORISM, CIVIL UNREST OR DISRUPTION OF MAIL SERVICE; (III) ADVERSE PUBLICITY REGARDING NUTRITIONAL SUPPLEMENTS; (IV) INABILITY TO RETAIN CUSTOMERS OF COMPANIES (OR MAILING LISTS) RECENTLY ACQUIRED; (V) INCREASED COMPETITION; (VI) INCREASED COSTS; (VII) LOSS OR RETIREMENT OF KEY MEMBERS OF MANAGEMENT; (VIII) INCREASES IN THE COST OF BORROWINGS AND/OR UNAVAILABILITY OF ADDITIONAL DEBT OR EQUITY CAPITAL; (IX) UNAVAILABILITY OF, OR INABILITY TO CONSUMMATE, ADVANTAGEOUS ACQUISITIONS IN THE FUTURE, INCLUDING THOSE THAT MAY BE SUBJECT TO BANKRUPTCY APPROVAL OR THE INABILITY OF THE COMPANY TO INTEGRATE ACQUISITIONS INTO THE MAINSTREAM OF ITS BUSINESS; (X) CHANGES IN GENERAL WORLDWIDE ECONOMIC AND POLITICAL CONDITIONS IN THE MARKETS IN WHICH THE COMPANY MAY COMPETE FROM TIME TO TIME; (XI) THE INABILITY OF THE COMPANY TO GAIN AND/OR HOLD MARKET SHARE OF ITS WHOLESALE AND/OR RETAIL CUSTOMERS ANYWHERE IN THE WORLD; (XII) UNAVAILABILITY OF ELECTRICITY IN CERTAIN GEOGRAPHICAL AREAS; (XIII) THE INABILITY OF THE COMPANY TO OBTAIN AND/OR RENEW INSURANCE AND/OR THE COSTS OF THE SAME; (XIV) EXPOSURE TO AND EXPENSE OF DEFENDING AND RESOLVING, PRODUCT LIABILITY CLAIMS AND OTHER LITIGATION; (XV) THE ABILITY OF THE COMPANY TO SUCCESSFULLY IMPLEMENT ITS BUSINESS STRATEGY; (XVI) THE INABILITY OF THE COMPANY TO MANAGE ITS RETAIL, WHOLESALE, MANUFACTURING AND OTHER OPERATIONS EFFICIENTLY; (XVII) CONSUMER ACCEPTANCE OF THE COMPANY'S PRODUCTS; (XVIII) THE INABILITY OF THE COMPANY TO RENEW LEASES FOR ITS RETAIL LOCATIONS; (XIX) INABILITY OF THE COMPANY'S RETAIL STORES TO ATTAIN OR MAINTAIN PROFITABILITY; (XX) THE ABSENCE OF CLINICAL TRIALS FOR MANY OF THE COMPANY'S PRODUCTS; (XXI) SALES AND EARNINGS VOLATILITY AND/OR TRENDS FOR THE COMPANY AND ITS MARKET SEGMENTS; (XXII) THE EFFICACY OF THE COMPANY'S INTERNET AND ON-LINE SALES AND MARKETING; (XXIII) FLUCTUATIONS IN FOREIGN CURRENCIES, INCLUDING THE BRITISH POUND AND THE EURO; (XXIV) IMPORT-EXPORT CONTROLS ON SALES TO FOREIGN COUNTRIES; (XXV) THE INABILITY OF THE COMPANY TO SECURE FAVORABLE NEW SITES FOR, AND DELAYS IN OPENING, NEW RETAIL LOCATIONS; (XXVI) INTRODUCTION OF AND COMPLIANCE WITH NEW FEDERAL, STATE, LOCAL OR FOREIGN LEGISLATION OR REGULATION OR ADVERSE DETERMINATIONS BY REGULATORS ANYWHERE IN THE WORLD (INCLUDING THE BANNING OF PRODUCTS) AND MORE PARTICULARLY PROPOSED GOOD MANUFACTURING PRACTICES IN THE UNITED STATES, THE FOOD SUPPLEMENTS DIRECTIVE AND TRADITIONAL HERBAL MEDICINAL PRODUCTS DIRECTIVE IN
1
EUROPE AND SECTION 404 REQUIREMENTS OF THE SARBANES-OXLEY ACT OF 2002; (XXVII) THE MIX OF THE COMPANY'S PRODUCTS AND THE PROFIT MARGINS THEREON; (XXVIII) THE AVAILABILITY AND PRICING OF RAW MATERIALS; (XXIX) RISK FACTORS DISCUSSED IN THE COMPANY'S FILINGS WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION; (XXX) ADVERSE EFFECTS ON THE COMPANY AS A RESULT OF INCREASED GASOLINE PRICES AND POTENTIALLY REDUCED TRAFFIC FLOW TO THE COMPANY'S RETAIL LOCATIONS; (XXXI) ADVERSE TAX DETERMINATIONS; (XXXII) THE LOSS OF A SIGNIFICANT CUSTOMER OF THE COMPANY; AND (XXXIII) OTHER FACTORS BEYOND THE COMPANY'S CONTROL.
THE COMPANY CANNOT BE CERTAIN THAT THE MEASURES TAKEN WILL BE SUFFICIENT TO MEET THE SECTION 404 REQUIREMENTS OF THE SARBANES-OXLEY ACT OF 2002.
READERS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON FORWARD-LOOKING STATEMENTS. THE COMPANY CANNOT GUARANTEE FUTURE RESULTS, TRENDS, EVENTS, LEVELS OF ACTIVITY, PERFORMANCE OR ACHIEVEMENTS. THE COMPANY DOES NOT UNDERTAKE AND SPECIFICALLY DECLINES ANY OBLIGATION TO UPDATE, REPUBLISH OR REVISE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER THE DATE HEREOF OR TO REFLECT THE OCCURRENCES OF UNANTICIPATED EVENTS.
CONSEQUENTLY, SUCH FORWARD-LOOKING STATEMENTS SHOULD BE REGARDED SOLELY AS THE COMPANY'S CURRENT PLANS, ESTIMATES AND BELIEFS.
INDUSTRY DATA USED THROUGHOUT THIS REPORT WAS OBTAINED FROM INDUSTRY PUBLICATIONS AND INTERNAL COMPANY ESTIMATES. WHILE THE COMPANY BELIEVES SUCH INFORMATION TO BE RELIABLE, ITS ACCURACY HAS NOT BEEN INDEPENDENTLY VERIFIED AND CANNOT BE GUARANTEED.
2
ITEM 1:
NBTY, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars and shares in thousands)
| |
March 31, 2005 |
September 30, 2004 |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $ | 38,268 | $ | 21,751 | |||||
| Accounts receivable, less allowance for doubtful accounts of $9,090 and $9,389, respectively | 67,176 | 86,113 | |||||||
| Inventories | 461,633 | 374,559 | |||||||
| Deferred income taxes | 32,062 | 32,062 | |||||||
| Prepaid expenses and other current assets | 47,441 | 62,835 | |||||||
| Total current assets | 646,580 | 577,320 | |||||||
Property, plant and equipment, net of accumulated depreciation of $265,344 and $241,822, respectively |
281,562 |
280,075 |
|||||||
| Goodwill | 228,576 | 221,429 | |||||||
| Other intangible assets, net | 131,944 | 136,541 | |||||||
| Other assets | 15,224 | 17,288 | |||||||
| Total assets | $ | 1,303,886 | $ | 1,232,653 | |||||
| Liabilities and Stockholders' Equity | |||||||||
| Current liabilities: | |||||||||
| Current portion of long-term debt | $ | 2,021 | $ | 3,205 | |||||
| Accounts payable | 98,636 | 97,635 | |||||||
| Accrued expenses and other current liabilities | 133,936 | 116,633 | |||||||
| Total current liabilities | 234,593 | 217,473 | |||||||
Long-term debt |
289,836 |
306,531 |
|||||||
| Deferred income taxes | 73,635 | 64,675 | |||||||
| Other liabilities | 5,354 | 4,176 | |||||||
| Total liabilities | 603,418 | 592,855 | |||||||
Commitments and contingencies |
|||||||||
Stockholders' equity: |
|||||||||
| Common stock, $.008 par; authorized 175,000 shares; issued and outstanding 67,185 shares at March 31, 2005, and 67,060 shares at September 30, 2004 | 537 | 536 | |||||||
| Capital in excess of par | 138,597 | 135,787 | |||||||
| Retained earnings | 531,898 | 481,302 | |||||||
| Accumulated other comprehensive income | 29,436 | 22,173 | |||||||
| Total stockholders' equity | 700,468 | 639,798 | |||||||
| Total liabilities and stockholders' equity | $ | 1,303,886 | $ | 1,232,653 | |||||
This should be read in conjunction with the Notes to Condensed Consolidated Financial Statements ("Notes") herein and the Consolidated Financial Statements in the Company's Form 10-K filed December 14, 2004 (the "2004 Form 10-K").
3
NBTY, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(Dollars and shares in thousands, except per share amounts)
| |
For the three months ended March 31, |
For the six months ended March 31, |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2005 |
2004 |
2005 |
2004 |
|||||||||||
| Net sales | $ | 442,714 | $ | 439,594 | $ | 862,983 | $ | 824,647 | |||||||
| Costs and expenses: | |||||||||||||||
| Cost of sales | 226,081 | 213,248 | 438,034 | 406,134 | |||||||||||
| Catalog printing, postage and promotion | 34,515 | 19,322 | 55,298 | 39,459 | |||||||||||
| Selling, general and administrative | 144,634 | 138,294 | 283,036 | 268,665 | |||||||||||
| 405,230 | 370,864 | 776,368 | 714,258 | ||||||||||||
| Income from operations | 37,484 | 68,730 | 86,615 | 110,389 | |||||||||||
| Other income (expense): | |||||||||||||||
| Interest | (5,881 | ) | (6,759 | ) | (11,573 | ) | (13,564 | ) | |||||||
| Miscellaneous, net | 110 | 540 | 2,101 | 2,047 | |||||||||||
| (5,771 | ) | (6,219 | ) | (9,472 | ) | (11,517 | ) | ||||||||
| Income before provision for income taxes | 31,713 | 62,511 | 77,143 | 98,872 | |||||||||||
| Provision for income taxes | 10,846 | 21,254 | 26,383 | 33,970 | |||||||||||
| Net income | $ | 20,867 | $ | 41,257 | $ | 50,760 | $ | 64,902 | |||||||
| Net income per share: | |||||||||||||||
| Basic | $ | 0.31 | $ | 0.62 | $ | 0.76 | $ | 0.97 | |||||||
| Diluted | $ | 0.30 | $ | 0.60 | $ | 0.73 | $ | 0.94 | |||||||
Weighted average common shares outstanding: |
|||||||||||||||
| Basic | 67,290 | 66,730 | 67,130 | 66,686 | |||||||||||
| Diluted | 69,291 | 69,098 | 69,137 | 68,997 | |||||||||||
This should be read in conjunction with the Notes herein and the Consolidated Financial Statements in the 2004 Form 10-K.
4
NBTY, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME
FOR THE YEAR ENDED SEPTEMBER 30, 2004 AND
SIX MONTHS ENDED MARCH 31, 2005
(Unaudited)
(Dollars and shares in thousands)
| |
Common Stock |
|
|
Treasury Stock |
|
|
|
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
|
|
Accumulated Other Comprehensive Income |
|
|
|||||||||||||||||||||
| |
Number of Shares |
Amount |
Capital in Excess of Par |
Retained Earnings |
Number of Shares |
Amount |
Total Stockholders' Equity |
Total Comprehensive Income |
||||||||||||||||||
| Balance, September 30, 2003 | 66,620 | $ | 533 | $ | 130,208 | $ | 369,453 | | $ | | $ | 14,605 | $ | 514,799 | ||||||||||||
| Components of comprehensive income: | ||||||||||||||||||||||||||
| Net income | | | | 111,849 | | | | 111,849 | $ | 111,849 | ||||||||||||||||
| Foreign currency translation adjustment and other, net of taxes | | | | | | | 7,568 | 7,568 | 7,568 | |||||||||||||||||
| $ | 119,417 | |||||||||||||||||||||||||
| Shares issued and contributed to ESOP | 100 | 1 | 2,472 | | | | | 2,473 | ||||||||||||||||||
| Exercise of stock options | 340 | 2 | 1,879 | | | | | 1,881 | ||||||||||||||||||
| Tax benefit from exercise of stock options | | | 1,228 | | | | | 1,228 | ||||||||||||||||||
| Balance, September 30, 2004 | 67,060 | 536 | 135,787 | 481,302 | | | 22,173 | 639,798 | ||||||||||||||||||
| Components of comprehensive income: | ||||||||||||||||||||||||||
| Net income | | | | 50,760 | | | | 50,760 | $ | 50,760 | ||||||||||||||||
| Foreign currency translation adjustment and other, net of taxes | | | | | | | 7,263 | 7,263 | 7,263 | |||||||||||||||||
| $ | 58,023 | |||||||||||||||||||||||||
Purchase of treasury shares, at cost |
|
|
|
|
8 |
(176 |
) |
|
(176 |
) |
||||||||||||||||
| Treasury stock retired | (8 | ) | | (12 | ) | (164 | ) | (8 | ) | 176 | | | ||||||||||||||
| Shares issued and contributed to ESOP | 100 | 1 | 2,437 | | | | | 2,438 | ||||||||||||||||||
| Exercise of stock options | 33 | | 191 | | | | | 191 | ||||||||||||||||||
| Tax benefit from exercise of stock options | | | 194 | | | | | 194 | ||||||||||||||||||
| Balance, March 31, 2005 | 67,185 | $ | 537 | $ | 138,597 | $ | 531,898 | | $ | | $ | 29,436 | $ | 700,468 | ||||||||||||
This should be read in conjunction with the Notes herein and the Consolidated Financial Statements in the 2004 Form 10-K.
5
NBTY, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars and shares in thousands)
| |
For the six months ended March 31, |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2005 |
2004 |
||||||||||
| Cash flows from operating activities: | ||||||||||||
| Net income | $ | 50,760 | $ | 64,902 | ||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Loss on disposal/sale of property, plant and equipment | 25 | 492 | ||||||||||
| Depreciation and amortization | 29,127 | 31,258 | ||||||||||
| Foreign currency transaction gain | (451 | ) | (240 | ) | ||||||||
| Amortization of deferred financing costs | 1,216 | 1,812 | ||||||||||
| Amortization of bond discount | 80 | 62 | ||||||||||
| Compensation expense for ESOP | 1,135 | 2,473 | ||||||||||
| Impairment on asset held for sale | 1,908 | | ||||||||||
| Gain on sale of business assets | (1,999 | ) | | |||||||||
| (Recovery of)/provision for doubtful accounts | (672 | ) | 1,298 | |||||||||
| Inventory reserves | 1,828 | 2,360 | ||||||||||
| Deferred income taxes | 3,957 | 5,095 | ||||||||||
| Tax benefit from exercise of stock options | 194 | 132 | ||||||||||
| Changes in operating assets and liabilities, net of acquisitions: | ||||||||||||
| Accounts receivable | 19,900 | (12,738 | ) | |||||||||
| Inventories | (85,296 | ) | 7,545 | |||||||||
| Prepaid expenses and other current assets | 16,400 | 16,444 | ||||||||||
| Other assets | 335 | 367 | ||||||||||
| Accounts payable | (1,154 | ) | (3,597 | ) | ||||||||
| Accrued expenses and other liabilities | 16,784 | (3,809 | ) | |||||||||
| Net cash provided by operating activities | 54,077 | 113,856 | ||||||||||
| Cash flows from investing activities: | ||||||||||||
| Purchase of property, plant and equipment | (21,605 | ) | (21,916 | ) | ||||||||
| Proceeds from sale of property, plant and equipment | 70 | 83 | ||||||||||
| Proceeds from sale of trademark | 30 | | ||||||||||
| Proceeds from sale of business assets | 5,766 | | ||||||||||
| Cash paid for acquisitions, net of cash acquired | (5,327 | ) | | |||||||||
| Proceeds from sale of bond investment | | 4,158 | ||||||||||
| Net cash used in investing activities | (21,066 | ) | (17,675 | ) | ||||||||
| Cash flows from financing activities: | ||||||||||||
| Principal payments under long-term debt agreements | (17,977 | ) | (98,027 | ) | ||||||||
| Payments for financing fees | | (500 | ) | |||||||||
| Proceeds from stock options exercised | 191 | 88 | ||||||||||
| Purchase of treasury stock | (176 | ) | | |||||||||
| Net cash used in financing activities | (17,962 | ) | (98,439 | ) | ||||||||
| Effect of exchange rate changes on cash and cash equivalents | 1,468 | 7,618 | ||||||||||
| Net increase in cash and cash equivalents | 16,517 | 5,360 | ||||||||||
Cash and cash equivalents at beginning of period |
21,751 |
49,349 |
||||||||||
| Cash and cash equivalents at end of period | $ | 38,268 | $ | 54,709 | ||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Cash paid during the period for interest | $ | 10,134 | $ | 11,798 | ||||||||
| Cash paid during the period for income taxes | $ | 17,398 | $ | 16,780 | ||||||||
Non-cash investing and financing information: |
||||||||||||
| During the six months ended March 31, 2005, the Company issued 100 shares of NBTY stock (having a total then market value of approximately $2,438) as a contribution to the NBTY ESOP plan. | ||||||||||||
During the six months ended March 31, 2004, the Company issued 100 shares of NBTY stock (having a total then market value of approximately $2,473) as a contribution to the NBTY ESOP plan. |
||||||||||||
This should be read in conjunction with the Notes herein and the Consolidated Financial Statements in the 2004 Form 10-K.
6